Cargando…

Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization

The development of acute thrombosis within the TIPS tract may be prevented by prophylactic anticoagulation; however, there is no evidence of the correct anticoagulation regimen after TIPS placement. The purpose of this single-center retrospective study was to evaluate the short-term occlusion rate o...

Descripción completa

Detalles Bibliográficos
Autores principales: Goessmann, Holger, Schuffenhauer, Verna, Kandulski, Arne, Weigand, Kilian, Jung, Ernst-Michael, Uller, Wibke, Scharf, Gregor, Stroszczynski, Cristian, Verloh, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217914/
https://www.ncbi.nlm.nih.gov/pubmed/35732875
http://dx.doi.org/10.1038/s41598-022-14388-3
_version_ 1784731763632766976
author Goessmann, Holger
Schuffenhauer, Verna
Kandulski, Arne
Weigand, Kilian
Jung, Ernst-Michael
Uller, Wibke
Scharf, Gregor
Stroszczynski, Cristian
Verloh, Niklas
author_facet Goessmann, Holger
Schuffenhauer, Verna
Kandulski, Arne
Weigand, Kilian
Jung, Ernst-Michael
Uller, Wibke
Scharf, Gregor
Stroszczynski, Cristian
Verloh, Niklas
author_sort Goessmann, Holger
collection PubMed
description The development of acute thrombosis within the TIPS tract may be prevented by prophylactic anticoagulation; however, there is no evidence of the correct anticoagulation regimen after TIPS placement. The purpose of this single-center retrospective study was to evaluate the short-term occlusion rate of transjugular intrahepatic portosystemic shunts (TIPSs) with polytetrafluorethylene (PTFE)-coated stents under consequent periprocedural full heparinization (target partial thromboplastin time [PTT]: 60–80 s). We analyzed TIPS placements that were followed up over a six-month period by Doppler ultrasound in 94 patients and compared the study group of 54 patients who received intravenous periprocedural full heparinization (target PTT: 60–80 s) without any other anticoagulation to patients with prolonged anticoagulation medication. The primary endpoint was TIPS patency after six months. The primary patency rate was 88.3% overall, and in the study group, 90.7%, with an early thrombosis rate of 3.2% (study group: 1.9%) and a primary assisted patency rate of 95.7% (study group: 96.3%). In the study group, one case of TIPS thrombosis occurred on the 23rd day after TIPS placement. Two patients underwent reintervention because of stenosis or buckling. Moreover, the target PTT was not attained in 8 of the 54 patent TIPSs. Four patients had an increased portosystemic pressure gradient, without stenosis, and the flow rate was corrected by increasing the TIPS diameter by dilation. Two-day heparinization seems sufficient to avoid early TIPS thrombosis over a six-month period.
format Online
Article
Text
id pubmed-9217914
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-92179142022-06-24 Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization Goessmann, Holger Schuffenhauer, Verna Kandulski, Arne Weigand, Kilian Jung, Ernst-Michael Uller, Wibke Scharf, Gregor Stroszczynski, Cristian Verloh, Niklas Sci Rep Article The development of acute thrombosis within the TIPS tract may be prevented by prophylactic anticoagulation; however, there is no evidence of the correct anticoagulation regimen after TIPS placement. The purpose of this single-center retrospective study was to evaluate the short-term occlusion rate of transjugular intrahepatic portosystemic shunts (TIPSs) with polytetrafluorethylene (PTFE)-coated stents under consequent periprocedural full heparinization (target partial thromboplastin time [PTT]: 60–80 s). We analyzed TIPS placements that were followed up over a six-month period by Doppler ultrasound in 94 patients and compared the study group of 54 patients who received intravenous periprocedural full heparinization (target PTT: 60–80 s) without any other anticoagulation to patients with prolonged anticoagulation medication. The primary endpoint was TIPS patency after six months. The primary patency rate was 88.3% overall, and in the study group, 90.7%, with an early thrombosis rate of 3.2% (study group: 1.9%) and a primary assisted patency rate of 95.7% (study group: 96.3%). In the study group, one case of TIPS thrombosis occurred on the 23rd day after TIPS placement. Two patients underwent reintervention because of stenosis or buckling. Moreover, the target PTT was not attained in 8 of the 54 patent TIPSs. Four patients had an increased portosystemic pressure gradient, without stenosis, and the flow rate was corrected by increasing the TIPS diameter by dilation. Two-day heparinization seems sufficient to avoid early TIPS thrombosis over a six-month period. Nature Publishing Group UK 2022-06-22 /pmc/articles/PMC9217914/ /pubmed/35732875 http://dx.doi.org/10.1038/s41598-022-14388-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Goessmann, Holger
Schuffenhauer, Verna
Kandulski, Arne
Weigand, Kilian
Jung, Ernst-Michael
Uller, Wibke
Scharf, Gregor
Stroszczynski, Cristian
Verloh, Niklas
Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization
title Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization
title_full Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization
title_fullStr Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization
title_full_unstemmed Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization
title_short Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization
title_sort retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217914/
https://www.ncbi.nlm.nih.gov/pubmed/35732875
http://dx.doi.org/10.1038/s41598-022-14388-3
work_keys_str_mv AT goessmannholger retrospectiveevaluationofearlythrombosisintransjugularintrahepaticportosystemicpolytetrafluoroethylenecoatedshuntsunder2daypostinterventionalheparinization
AT schuffenhauerverna retrospectiveevaluationofearlythrombosisintransjugularintrahepaticportosystemicpolytetrafluoroethylenecoatedshuntsunder2daypostinterventionalheparinization
AT kandulskiarne retrospectiveevaluationofearlythrombosisintransjugularintrahepaticportosystemicpolytetrafluoroethylenecoatedshuntsunder2daypostinterventionalheparinization
AT weigandkilian retrospectiveevaluationofearlythrombosisintransjugularintrahepaticportosystemicpolytetrafluoroethylenecoatedshuntsunder2daypostinterventionalheparinization
AT jungernstmichael retrospectiveevaluationofearlythrombosisintransjugularintrahepaticportosystemicpolytetrafluoroethylenecoatedshuntsunder2daypostinterventionalheparinization
AT ullerwibke retrospectiveevaluationofearlythrombosisintransjugularintrahepaticportosystemicpolytetrafluoroethylenecoatedshuntsunder2daypostinterventionalheparinization
AT scharfgregor retrospectiveevaluationofearlythrombosisintransjugularintrahepaticportosystemicpolytetrafluoroethylenecoatedshuntsunder2daypostinterventionalheparinization
AT stroszczynskicristian retrospectiveevaluationofearlythrombosisintransjugularintrahepaticportosystemicpolytetrafluoroethylenecoatedshuntsunder2daypostinterventionalheparinization
AT verlohniklas retrospectiveevaluationofearlythrombosisintransjugularintrahepaticportosystemicpolytetrafluoroethylenecoatedshuntsunder2daypostinterventionalheparinization